OXTR gene
Zealand Pharma and OTR Therapeutics in multi-program strategic collaboration for metabolic diseases
Zealand Pharma; OTR Therapeutics; strategic collaboration; license agreement; metabolic diseases; obesity; oral small-molecule therapeutics; R&D partnership; China biotech; upfront payment; milestone payments; royalties